EXS-74539

N/A

Report date: 2026/04/09 20:00:21
NME

Base Information

Drug NameEXS-74539
Drug Alias NameEXS-74539'539REC-4539REC4539
ClassificationSmall molecules
Mechanisms of ActionLysine-specific histone demethylase 1 inhibitors
TargetsLysine-specific histone demethylase 1
Therapy Area/IndicationsSolid tumoursProstatic NeoplasmsSmall Cell Lung Carcinoma +[12] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRecursion Pharmaceuticals IncBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesRecursion Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic NeoplasmsSmall Cell Lung Carcinoma +[12] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A